Viatris Inc
VTRSAPI behind this page
VTRS Q2 2025 request
Playground key active
/api/financials?ticker=VTRS&year=2025&quarter=2
Pick an endpoint and run the request.Income Statement
| Metric | Q2 2025 | Q2 2024 | YoY |
|---|---|---|---|
| Revenue | 3,569 | 3,785.9 | -5.7% |
Show Product Lines breakouts |
|||
| Amitiza ® | 41.6 | 36.9 | +12.7% |
| Brands | 2,284.5 | 2,363.1 | -3.3% |
| Brands · Developed Markets Segment | 1,121.4 | 1,233.8 | -9.1% |
| Brands · Emerging Markets Segment | 416.1 | 395.2 | +5.3% |
| Brands · Greater China | 586.5 | 535.7 | +9.5% |
| Brands · Japan, Australia and New Zealand Segment | 160.5 | 198.4 | -19.1% |
| Celebrex ® | 70 | 72.2 | -3.0% |
| Creon ® | 91.4 | 78.2 | +16.9% |
| Dymista ® | 48.4 | 55 | -12.0% |
| Effexor ® | 63.1 | 62.7 | +0.6% |
| EpiPen® Auto-Injectors | 136.8 | 115.5 | +18.4% |
| Generics | 1,284.5 | 1,422.8 | -9.7% |
| Generics · Developed Markets Segment | 997.9 | 1,085.4 | -8.1% |
| Generics · Emerging Markets Segment | 139 | 182.9 | -24.0% |
| Generics · Greater China | 2.4 | 3.3 | -27.3% |
| Generics · Japan, Australia and New Zealand Segment | 145.2 | 151.2 | -4.0% |
| Lipitor | 387.9 | 348.4 | +11.3% |
| Lyrica ® | 128.1 | 124.3 | +3.1% |
| Norvasc | 182.7 | 161.9 | +12.8% |
| Viagra ® | 100.3 | 106.1 | -5.5% |
| Xalabrands | 40.7 | 45.6 | -10.7% |
| Xanax ® | 33.9 | 35.4 | -4.2% |
| Yupelri ® | 66.6 | 54.5 | +22.2% |
| Zoloft ® | 61.1 | 58.9 | +3.7% |
Show Business Segments breakouts |
|||
| Developed Markets Segment · Operating Segments | 2,119.3 | 2,319.2 | -8.6% |
| Emerging Markets Segment · Operating Segments | 555.1 | 578.1 | -4.0% |
| Greater China · Operating Segments | 588.9 | 539 | +9.3% |
| Japan, Australia and New Zealand Segment · Operating Segments | 305.7 | 349.6 | -12.6% |
| Other Revenue | 13.1 | 10.7 | +22.4% |
Show Product Lines breakouts |
|||
| Product And Service Other · Developed Markets Segment | 10.3 | 5.9 | +74.6% |
| Product And Service Other · Emerging Markets Segment | 1.8 | 4.2 | -57.1% |
| Product And Service Other · Japan, Australia and New Zealand Segment | 1 | 0.2 | +400.0% |
| Revenue | 3,582.1 | 3,796.6 | -5.6% |
Show Business Segments breakouts |
|||
| Developed Markets Segment | 2,129.6 | 2,325.1 | -8.4% |
| Emerging Markets Segment | 556.9 | 582.3 | -4.4% |
| Greater China | 588.9 | 539.4 | +9.2% |
| Japan, Australia and New Zealand Segment | 306.7 | 349.8 | -12.3% |
| Cost of Revenue | 2,249.2 | 2,351.2 | -4.3% |
| Gross Profit | 1,332.9 | 1,445.4 | -7.8% |
| Research & Development | 218.8 | 204.1 | +7.2% |
Show Consolidation Items breakouts |
|||
| Material Reconciling Items | 218.8 | 204.1 | +7.2% |
| Selling, General & Administrative | 928.7 | 1,037 | -10.4% |
| Gain Loss Related To Litigation Settlement | -47.6 | 131 | -136.3% |
Show Consolidation Items breakouts |
|||
| Material Reconciling Items | -47.6 | 131 | -136.3% |
| Operating Expenses | 1,099.9 | 1,685.3 | -34.7% |
| Operating Income | 233 | -239.9 | +197.1% |
Show Business Segments breakouts |
|||
| Developed Markets Segment · Operating Segments | 875.5 | 1,007.7 | -13.1% |
| Emerging Markets Segment · Operating Segments | 238.1 | 232.7 | +2.3% |
| Greater China · Operating Segments | 401.8 | 349.4 | +15.0% |
| Japan, Australia and New Zealand Segment · Operating Segments | 83.7 | 101.3 | -17.4% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 1,599.1 | 1,691.1 | -5.4% |
| Interest Expense | 116.6 | 145.8 | -20.0% |
| Other Non-Operating Income (Expense) | 333.5 | 6.1 | +5367.2% |
Show Disposal Group Classification breakouts |
|||
| OTC Business | -12.4 | -6 | -106.7% |
| Income Before Taxes | -217.1 | -391.8 | +44.6% |
| Income Tax Expense (Benefit) | -212.5 | -65.4 | -224.9% |
| Net Income Loss Available To Common Stockholders Basic | -4.6 | -326.4 | +98.6% |
| Wtd Avg Shares (Basic) | 1,173 | 1,191.1 | -1.5% |
| Wtd Avg Shares (Diluted) | 1,173 | 1,191.1 | -1.5% |
| Comprehensive Income | 201.9 | -360.6 | +156.0% |
| Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax (Q) | — | — | — |
Show Derivative Risk breakouts |
|||
| Foreign Exchange Contract · Cash Flow Hedging | -21.6 | 12.9 | -267.4% |
| Foreign Exchange Contract · Net Investment Hedging | -4.6 | 3.3 | -239.4% |
| Foreign Exchange Contract · Nondesignated | -233 | 45.1 | -616.6% |
| Interest Rate Swap · Cash Flow Hedging | -1 | -1.3 | +23.1% |
| Interest Rate Swap · Net Investment Hedging | -40.3 | 5.1 | -890.2% |
Balance Sheet
| Metric | Q2 2025 | Q2 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 566.4 | 917.2 | -38.2% |
| Accounts Receivable | 3,258.1 | 3,566.9 | -8.7% |
Show Accounts Notes Loans And Financing Receivable By Receivable Type breakouts |
|||
| Variable Consideration | 2,464.1 | 2,547 | -3.3% |
| Inventory | 4,264.3 | 3,942.1 | +8.2% |
| Prepaid Expenses & Other Current Assets | 1,685.8 | — | — |
| Total Current Assets | 9,774.6 | 11,792.1 | -17.1% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 2,642.6 | 2,662.6 | -0.8% |
| Goodwill | 6,748.3 | — | — |
Show Business Segments breakouts |
|||
| Developed Markets Segment | 5,019.2 | — | — |
| Emerging Markets Segment | 801.3 | — | — |
| Greater China | 927.8 | — | — |
| Deferred Tax Assets | 924.3 | 685.3 | +34.9% |
| Other Non-Current Assets | 1,997.9 | 2,445.1 | -18.3% |
| Total Assets | 38,411.5 | 45,330 | -15.3% |
| Operating Lease Right-of-Use Assets | 276.3 | 273.4 | +1.1% |
| Intangible Assets | 15,521.9 | 17,526.9 | -11.4% |
| Other Assets | |||
| Intangible Assets Net Excluding Goodwill | 16,323.8 | 18,419 | -11.4% |
| Current Liabilities | |||
| Accounts Payable Trade Current | 1,782.6 | 1,957.5 | -8.9% |
| Current Portion of Long-Term Debt | 1,680.7 | 2,367.4 | -29.0% |
| Other Liabilities Current | 3,670.1 | — | — |
| Total Current Liabilities | 7,133.4 | 7,709.2 | -7.5% |
| Debt Current | 1,673.1 | — | — |
Show Debt Instrument breakouts |
|||
| Other Current Portion of Long-term Debt | 0.8 | — | — |
| Non-Current Liabilities | |||
| Long-Term Debt | 12,791.6 | 14,731.2 | -13.2% |
Show Debt Instrument breakouts |
|||
| 2028 Euro Senior Notes · Senior Notes | 881.1 | 800.1 | +10.1% |
| 2028 Senior Notes [Member] · Senior Notes | 749.4 | 749.2 | 0.0% |
| 2043 Senior Notes (5.400% coupon) · Senior Notes | 497.6 | 497.5 | 0.0% |
| 2046 Senior Notes (5.250% coupon) · Senior Notes | 999.9 | 999.9 | 0.0% |
| 2048 Senior Notes [Member] · Senior Notes | 747.9 | 747.9 | 0.0% |
| Other Long Term Debt [Member] | 2.2 | 2.1 | +4.8% |
| Deferred Tax Liabilities | 1,080.8 | 1,573.8 | -31.3% |
| Other Non-Current Liabilities | 1,835.2 | 1,795.8 | +2.2% |
| Total Liabilities | 22,841 | 25,810 | -11.5% |
| Long-Term Debt (Q) | — | — | — |
Show Debt Instrument breakouts |
|||
| 2020 Euro Senior Notes | 277.7 | 248.6 | +11.7% |
| 2027 Euro Senior Notes · Net Investment Hedging | 850 | 850 | 0.0% |
| 2027 Euro Senior Notes · Senior Notes | 1,019.5 | 934.6 | +9.1% |
| 2027 Senior Notes · Senior Notes | 761.4 | 767 | -0.7% |
| 2028 Euro Senior Notes · Net Investment Hedging | 750 | 750 | 0.0% |
| 2030 Senior Notes · Senior Notes | 1,492.9 | 1,501 | -0.5% |
| 2032 Euro Senior Notes · Net Investment Hedging | 1,250 | 1,250 | 0.0% |
| 2032 Euro Senior Notes · Senior Notes | 1,560.7 | 1,429.4 | +9.2% |
| 2040 Senior Notes · Senior Notes | 1,633.6 | 1,640.6 | -0.4% |
| 2050 Senior Notes · Senior Notes | 2,189.2 | 2,194 | -0.2% |
| YEN Term Loan · Net Investment Hedging | 40,000 | 40,000 | 0.0% |
Show Derivative Instruments Gain Loss By Hedging Relationship breakouts |
|||
| Net Investment Hedging | 2,850 | 6,200 | -54.0% |
| Operating Lease Liabilities | 182 | 191.9 | -5.2% |
| Stockholders' Equity | |||
| Common Stock | 12.5 | 12.3 | +1.6% |
| Additional Paid-In Capital | 18,998.2 | 18,853.3 | +0.8% |
| Retained Earnings | 80 | — | — |
| Accumulated Other Comprehensive Income | -2,664.4 | — | — |
| Stockholders Equity Parent Before Treasury Stock | 16,426.3 | 20,024.3 | -18.0% |
| Treasury Stock Value | 855.8 | 504.3 | +69.7% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 15,570.5 | 19,520 | -20.2% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | -2,664.4 | -2,975.2 | +10.4% |
| Additional Paid In Capital | 18,998.2 | 18,853.3 | +0.8% |
| Common Stock | 12.5 | 12.3 | +1.6% |
| Retained Earnings | 80 | 4,133.9 | -98.1% |
| Total Liabilities & Equity | 38,411.5 | 45,330 | -15.3% |
| Total Stockholders' Equity (Q) | — | — | — |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment | 253.8 | 261.7 | -3.0% |
| Accumulated Gain Loss Net Cash Flow Hedge Parent | -12.8 | 20.2 | -163.4% |
| Accumulated Net Unrealized Investment Gain Loss | -0.6 | -1.4 | +57.1% |
| Accumulated Other Comprehensive Income | -2,664.4 | -2,975.2 | +10.4% |
| Accumulated Translation Adjustment | -2,985 | -3,678.9 | +18.9% |
| Aoci Derivative Qualifying As Hedge Excluded Component Parent | 80.2 | 423.2 | -81.0% |
Cash Flow Statement
| Metric | YTD Q2 2025 | YTD Q2 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation & Amortization | 1,343 | 1,477.3 | -9.1% |
| Stock-Based Compensation | 92.3 | 81.4 | +13.4% |
| Deferred Income Taxes | -91.1 | -206.3 | +55.8% |
| Gain Loss On Sale Of Business | 80.7 | 188.4 | -57.2% |
Show Disposal Group Classification breakouts |
|||
| Disposal Group Held For Sale Or Disposed Of By Sale Not Discontinued Operations · Other Nonoperating Income Expense | -80.7 | — | — |
| Payments To Acquire In Process Research And Development Other | 15 | -12.7 | +218.1% |
| Other Non-Cash Items | 726.3 | -244.9 | +396.6% |
| Changeinnoncashlitigationsettlementsnet | -97 | 214 | -145.3% |
| Change in Accounts Receivable | 158.4 | 32.6 | +385.9% |
| Change in Inventory | -232.7 | -558.8 | +58.4% |
| Increase Decrease In Accounts Payable Trade | -189.7 | 56.3 | -436.9% |
| Increase Decrease In Accrued Income Taxes Payable | -366.6 | 18.7 | -2060.4% |
| Increase Decrease In Other Operating Capital Net | -573.6 | -160.8 | -256.7% |
| Net Cash from Operations | 755.2 | 993.7 | -24.0% |
| Investing Activities | |||
| Capital Expenditures | -95.5 | -108.6 | +12.1% |
| Payments To Acquire Marketable Securities | -10.9 | -13.3 | +18.0% |
| Proceeds From Sale And Maturity Of Marketable Securities | 10.9 | 13.3 | -18.0% |
| Other Investing Activities | -20 | -11.7 | -70.9% |
| Proceeds From Refund Of In Process Research And Development | -15 | 12.7 | -218.1% |
| Proceeds From Sale Of Productive Assets | 12.9 | 1.4 | +821.4% |
| Net Cash from Investing | -117.6 | 221.5 | -153.1% |
| Financing Activities | |||
| Share Repurchases | 350.4 | 250 | +40.2% |
| Proceeds From Repayments Of Short Term Debt | 1.4 | — | — |
| Tax Withholding for Share Compensation | -29.5 | -32.1 | +8.1% |
| Payments Of Merger Related Costs Financing Activities | -13.1 | -31.5 | +58.4% |
| Payments Of Financing Costs | -1 | — | — |
| Payments To Minority Shareholders | -283.1 | -288.3 | +1.8% |
| Proceeds From Issuance Of Common Stock | 1.3 | 1.3 | 0.0% |
| Proceeds From Payments For Other Financing Activities | -155 | 128.8 | -220.3% |
| Net Cash from Financing | -829.4 | -1,273.5 | +34.9% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 23.5 | -16.8 | +239.9% |
| Net Change in Cash | -168.3 | -75.1 | -124.1% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 567.8 | 918.5 | -38.2% |
Values in millions USD. Source: SEC EDGAR 10-Q filing.